In silico study reveals strong binding affinity and stability of novel tacrine-based carbamates against acetylcholinesterase, highlighting their potential as Alzheimer's disease therapeutics.
> 0.93) show the influence of steric and hydrogen bond donor effects on activity. Then, four new derivatives were proposed and tested. The ADMET analysis revealed good pharmacokinetic properties and low predicted toxicity. The DFT calculations characterized the electronic properties of the designed derivatives, and the docking results showed stronger contacts within the active sites of TcAChE (2CKM) and hAChE (4EY7). The selected complexes with both AChE structures were stable in the molecular dynamics simulations for 200 ns. The binding energies and stable conformational behavior of the selected complexes were further confirmed by MM-GBSA, PCA, FEL and DCCM analyses. Overall, the results indicate that the designed derivatives could be promising candidates for AChE inhibition in Alzheimer's disease.
No takes yet. Share an insight, caveat, or question.
Ouarti et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: